LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models. [PDF]
Podolski-Renić A +8 more
europepmc +1 more source
Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors. [PDF]
Patel MR +9 more
europepmc +1 more source
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial. [PDF]
Hamilton EP +13 more
europepmc +1 more source
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs. [PDF]
Sadagopan A +7 more
europepmc +1 more source
Integrative Transcriptomics Identifies Ubiquitination-Related Genes <i>BIRC2, COPS5</i>, and <i>TBK1</i> as Novel Biomarkers of T-Cell Dysregulation in Amyotrophic Lateral Sclerosis. [PDF]
Jiang A +5 more
europepmc +1 more source
Genomics of ovarian cancers and the potential of precision medicine. [PDF]
Jarratt A +3 more
europepmc +1 more source
Overcoming Resistance in Triple-Negative Breast Cancer: A Translational Perspective on Next-Generation DNA Damage Response Inhibitors and Synthetic Lethality. [PDF]
Jończyk J +4 more
europepmc +1 more source
Homologous Recombination Proficiency in High-Grade Serous Epithelial Ovarian Cancer Tumors: The Dark Side of the Moon. [PDF]
Pavanello M +3 more
europepmc +1 more source
Editorial on Special Issue: "Novel Therapeutic Strategies for Glioblastoma". [PDF]
Podolski-Renić A, Dinić J, Pešić M.
europepmc +1 more source
Advances in Systemic Therapy for Ovarian Cancer Over the Past Decade: A Clinical and Molecular Perspective. [PDF]
Abramiuk M +6 more
europepmc +1 more source

